ABBVIE LTD
Company Information
- Company Number
- 08004972
- Registered Address
- Abbvie House Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, England, SL6 4UB
- Status
- Active
- Employee Count
- 1000.0
- Turnover
- 254292000.0
- EBITDA
- -17618000.0
Additional Details
- Website
- https://juvederm.co.uk/
- Company Type
- Private limited Company
- Incorporated On
- 23 March 2012
- Nature of Business
- 46460 - Wholesale of pharmaceutical goods
- Industries
- Healthcare And Wellbeing
- Region
- South East
Company Location
Loading map...
Financial Metrics
Time to Pay
Payment Timeline
Payment Features
Payment Time Trends
Payment Distribution Trends
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jul 2023 - 31 Dec 2023 | 31 Jan 2024 | 70 | 15% | 59% | 26% | 39% |
| 01 Jan 2023 - 30 Jun 2023 | 31 Jul 2023 | 64 | 15% | 61% | 24% | 38% |
| 01 Jul 2022 - 31 Dec 2022 | 31 Jan 2023 | 67 | 16% | 57% | 27% | 42% |
| 01 Jan 2022 - 30 Jun 2022 | 31 Jan 2023 | 59 | 14% | 59% | 27% | 42% |
| 01 Jan 2022 - 30 Jun 2022 | 27 Jul 2022 | |||||
| 01 Jul 2021 - 31 Dec 2021 | 28 Jan 2022 | 61 | 15% | 65% | 20% | 36% |
| 01 Jan 2021 - 30 Jun 2021 | 26 Jul 2021 | 59 | 16% | 67% | 17% | 33% |
| 01 Jul 2020 - 31 Dec 2020 | 27 Jan 2021 | 66 | 19% | 62% | 19% | 36% |
| 01 Jan 2020 - 30 Jun 2020 | 30 Jul 2020 | 59 | 17% | 63% | 20% | 38% |
| 01 Jul 2019 - 31 Dec 2019 | 29 Jan 2020 | 46 | 24% | 66% | 10% | 34% |
| 01 Jan 2019 - 30 Jun 2019 | 29 Jul 2019 | 49 | 21% | 66% | 13% | 35% |
| 01 Jan 2019 - 30 Jun 2019 | 29 Jul 2019 | |||||
| 01 Jul 2018 - 31 Dec 2018 | 27 Jan 2019 | 47 | 21% | 68% | 11% | 38% |
| 01 Jan 2018 - 30 Jun 2018 | 30 Jul 2018 | 52 | 19% | 67% | 14% | 40% |
Company Summary
AbbVie Ltd is a global pharmaceutical company that focuses on discovering, developing and commercializing innovative medicines and healthcare solutions
The company was established in 2013 and is headquartered in Berkshire, UK
The company's sustainability program is centered around three key pillars: access to healthcare, environmental stewardship, and ethical business practices
They strive to increase access to their medicines for underserved populations, reduce their environmental impact and maintain the highest ethical standards in their operations
AbbVie Ltd offers a wide range of products and services in various therapeutic areas including immunology, oncology, neuroscience, and virology
Their portfolio includes well-known brands such as Humira, Imbruvica, and Skyrizi, among others
The key people at AbbVie Ltd include Mr
Richard A
Gonzalez, the Chairman and CEO, and Ms
Laura J
Schumacher, the Vice Chairman of the Board and President of Global Legal, Regulatory and External Affairs
They lead a team of dedicated employees who are committed to making a positive impact in the healthcare industry
To learn more about AbbVie Ltd and their products and services, you can visit their website at www.abbvie.co.uk
Their registered office address is at AbbVie House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4UB, UK
Company Review
Trend Analysis
The average time taken for ABBVIE LTD to pay invoices to suppliers has increased from 52 days in the first period to 70 days in the most recent period. This represents a 34.6% increase in the average time taken to pay invoices.
Volatility Analysis
The volatility of ABBVIE LTD's payment patterns can be seen in the fluctuations of the percentages of invoices paid within 30 days and between 31 and 60 days. This suggests that the company's payment practices are not consistent and may be influenced by various factors.
Summary Analysis
Overall, there has been a significant increase in the average time taken for ABBVIE LTD to pay invoices, with a steady increase in the percentage of invoices paid later than 60 days. This trend could potentially be due to changes in the company's financial situation or payment policies. The company has also shown some fluctuations in their payment patterns, with a slight increase in the percentage of invoices paid within 30 days in the most recent period.
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
Standard payment terms are 60 days from date of invoice however, these may vary depending on the type of vendor.
Were there any changes to the standard payment terms in the reporting period?
No
Any other information about payment terms
No changes
Maximum contractual payment period agreed
90
Dispute Resolution Process
AbbVie has a Central Accounts Payable team known as the Invoice Resolution team (IRT) to deal with queries such as payment enquiries, invoice issues or unpaid items.
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
